MG
PFE icon

Mather Group’s Pfizer PFE Stock Holding History

Mather Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$761K Sell
31,616
-2,150
-6% -$56.2K 0.01% 440
2026
Q1 		$948K Buy
33,766
+10,994
+48% +$293K 0.01% 343
2025
Q4 		$567K Buy
22,772
+10,363
+84% +$261K 0.01% 384
2025
Q3 		$316K Buy
12,409
+741
+6% +$18.3K ﹤0.01% 504
2025
Q2 		$283K Sell
11,668
-10,517
-47% -$245K ﹤0.01% 516
2025
Q1 		$562K Buy
22,185
+1,978
+10% +$51.8K 0.01% 353
2024
Q4 		$536K Sell
20,207
-4,602
-19% -$125K 0.01% 346
2024
Q3 		$718K Sell
24,809
-25,734
-51% -$751K 0.01% 289
2024
Q2 		$1.4M Buy
50,543
+23,989
+90% +$660K 0.02% 220
2024
Q1 		$764K Sell
26,554
-1,179
-4% -$32.7K 0.01% 263
2023
Q4 		$798K Sell
27,733
-6,436
-19% -$195K 0.01% 261
2023
Q3 		$1.13M Buy
34,169
+8,857
+35% +$313K 0.02% 200
2023
Q2 		$928K Sell
25,312
-10,537
-29% -$410K 0.01% 243
2023
Q1 		$1.46M Sell
35,849
-16,274
-31% -$703K 0.03% 168
2022
Q4 		$2.67M Buy
52,123
+2,709
+5% +$130K 0.05% 120
2022
Q3 		$2.16M Buy
49,414
+7,601
+18% +$369K 0.05% 125
2022
Q2 		$2.19M Buy
41,813
+2,338
+6% +$119K 0.05% 120
2022
Q1 		$2.04M Buy
39,475
+17,910
+83% +$929K 0.04% 108
2021
Q4 		$1.27M Buy
21,565
+6,875
+47% +$341K 0.02% 130
2021
Q3 		$632K Sell
14,690
-386
-3% -$17.1K 0.02% 147
2021
Q2 		$590K Buy
15,076
+163
+1% +$6.34K 0.01% 146
2021
Q1 		$540K Sell
14,913
-677
-4% -$24K 0.02% 142
2020
Q4 		$574K Sell
15,590
-909
-6% -$33.3K 0.02% 126
2020
Q3 		$574K Sell
16,499
-1,076
-6% -$37.7K 0.02% 125
2020
Q2 		$545K Buy
+17,575
New +$597K 0.03% 125

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mather Group's PFE Position: Q2 2026 in Review

Mather Group reduced its Pfizer (PFE) stake by 6.4% in Q2 2026, selling an estimated $56.2K and leaving 31,616 shares worth $761K. The position accounts for 0.01% of the portfolio, ranked #440.

Mather Group first reported a position in PFE in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.67M in Q4 2022. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Mather Group held 31,616 shares of Pfizer worth $761K as of Q2 2026.
  • Mather Group sold 2,150 Pfizer shares in Q2 2026, an estimated $56.2K.
  • Pfizer made up 0.01% of Mather Group's portfolio in Q2 2026, its #440 holding.
  • Mather Group first reported a position in Pfizer in Q2 2020 and has held it in 25 quarters since.
  • Mather Group's Pfizer position peaked at $2.67M in Q4 2022.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.